Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

AnaSpec Introduces BAFF Protein

Published: Wednesday, October 06, 2010
Last Updated: Wednesday, October 06, 2010
Bookmark and Share
Naïve B-cells when treated with 20-1000 ng/ml BAFF protein shows increased IgG secretion.

AnaSpec announces the release of a recombinant human BAFF protein. Naïve B-cells, treated with 20-1000 ng/ml BAFF protein prepared by AnaSpec, has been showing increased IgG secretion compared to 2 leading commercial sources.

The sequence (Accession # NP_006564) corresponding to the extracellular domain of human BAFF along with a 6x His tag was expressed in E. coli. Recombinant human BAFF was purified from urea denatured bacterial lysate using immobilized metal affinity chromatography (IMAC) and refolded into its active state using a proprietary technique.

The molecular weight of the recombinant human BAFF is 17.2 kDa. Containing less than 0.1 EU of endotoxin per 1 µg of protein as determined by LAL assay, the activity of BAFF was determined by its ability to stimulate production of immunoglobulin molecules such as IgG, IgA, and IgM in isolated mouse B-lymphocytes. Purified recombinant human BAFF is supplied as sterile and frozen condition at 0.1 mg/ml in 1 x PBS buffer with 5 mM DTT, pH=7.5.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

AnaSpec Signs Distribution Agreement with Gene X Press
Both company’s announces non-exclusive distributor agreement that will allow Gene X Press to distribute AnaSpec’s catalog and custom products throughout Chile.
Friday, February 18, 2011
AnaSpec Showcases Premium Quality of Fluorescent Nucleic Acid Probes
Company showcases cell-impermeant and cell-permeant nucleic acid stains for detecting nucleic acids for cDNA synthesis and cloning, RNA transcription and transfection.
Wednesday, February 02, 2011
AnaSpec Signs Distribution Agreement with Bioeasy Diagnostica
Non-exclusive distributor agreement allows Bioeasy to distribute AnaSpec’s catalog and custom products throughout Brazil.
Friday, June 18, 2010
AnaSpec Products Used in Over 400 Patents
As compiled by Google Patent Search, the number of patents citing AnaSpec’s products has passed 400.
Monday, January 25, 2010
AnaSpec to Host Bone Marrow Donor Drive
The company has partnered with AADP to host a bone marrow donor drive on its campus on February 1, 2010.
Tuesday, January 19, 2010
AnaSpec Introduces HiLyte Fluor™ 750
According to company, the new HiLyte Fluor™ 750 dye is the longest-wavelength HiLyte Fluor™ dye currently available.
Monday, January 04, 2010
AnaSpec Signs Distribution Agreement with Bioeksma UAB
The agreement allows Bioeksma UAB to distribute AnaSpec’s catalog and custom products throughout Lithuania and Latvia.
Thursday, June 04, 2009
AnaSpec Launches new Headquarters in Fremont, California
Company announces the launch of its 44,010 square foot facility to offer all top of the line lab/R&D equipment and services.
Wednesday, April 29, 2009
AnaSpec Signs Distribution Agreement with Yope Biotechnology
The non-exclusive distributor agreement allows Yope Biotechnology to distribute AnaSpec’s catalog and custom products throughout China.
Wednesday, December 03, 2008
AnaSpec Establishes new Dedicated GMP Manufacturing Facility
The expansion provides an additional 5000 sq. ft. of GMP space including two class 10,000 clean rooms.
Monday, November 17, 2008
RayBiotech and AnaSpec Sign Licensing Agreement for HiLyte™ Dyes
The licensing agreement allows RayBiotech to label antibodies with AnaSpec HiLytePlus™ and HiLyte Fluor™ dyes and integrate into protein and antibody arrays.
Tuesday, September 16, 2008
AnaSpec and Cyclex Sign Licensing Agreement for Deacetylase Activity Assay Kits
The licensing agreement allows AnaSpec to make, use, and sell deacetylase activity assay kits and the related products.
Monday, September 15, 2008
Novus Biologicals and AnaSpec Sign Licensing Agreement for HiLyte™ Dyes
The licensing agreement allows Novus to label Novus antibodies with AnaSpec HiLytePlus™ and HiLyte Fluor™ dyes.
Tuesday, July 29, 2008
AnaSpec’s Published References Passes 600
As compiled by Stanford University’s Highwire Press, the number of published papers that cite AnaSpec’s products has passed 600.
Monday, May 05, 2008
AnaSpec Introduces Longest Wavelength Assay Kit for TACE Detection
AnaSpec has introduced the SensoLyte™ 520 TACE Assay Kit, offering fluorescence detection at the wavelengths.
Thursday, August 23, 2007
Scientific News
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
New Gene Therapy for Vision Loss From a Mitochondrial Disease
NIH-funded study shows success in targeting mitochondrial DNA in mice.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
Self-Propelled Powder to Stop Bleeding
UBC researchers have created the first self-propelled particles capable of delivering coagulants against the flow of blood to treat severe bleeding, a potentially huge advancement in trauma care.
Five New Genetic Variants Linked to Brain Cancer Identified
The biggest ever study of DNA from people with glioma – the most common form of brain cancer – has discovered five new genetic variants associated with the disease.
Antibody Treatment Efficacious in Psoriasis
An experimental, biologic treatment, brodalumab, achieved 100 percent reduction in psoriasis symptoms in twice as many patients as a second, commonly used treatment, according to the results of a multicenter clinical trial led by Mount Sinai researchers.
Predictive Model for Breast Cancer Progression
Biomedical engineers have demonstrated a proof-of-principle technique that could give women and their oncologists more personalized information to help them choose options for treating breast cancer.
Probing the Forces Involved in Creating The Mitotic Spindle
Scientists at The Rockefeller University reveal new insights into the mechanical forces that govern elements of the mitotic spindle formation.
Identifying Cancer’s Food Sensors May Help to Halt Tumour Growth
Oxford University researchers have identified a protein used by tumours to help them detect food supplies. Initial studies show that targeting the protein could restrict cancerous cells’ ability to grow.
Fatty Liver Disease and Scarring Have Strong Genetic Component
Researchers say that hepatic fibrosis, which involves scarring of the liver that can result in dysfunction and, in severe cases, cirrhosis and cancer, may be as much a consequence of genetics as environmental factors.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos